phosphatidylcholines has been researched along with Leishmaniasis, Mucocutaneous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adedoyin, A; Anaissie, E; Bernardo, JF; Bolsack, LE; Boyle, A; Branch, RA; DeValeriola, D; DeWit, S; Horwith, G; Kelly, E; Klasterksy, J; Llanos-Cuentas, A; Lopez-Berestein, G; Sculier, JP; Swenson, CE | 1 |
1 trial(s) available for phosphatidylcholines and Leishmaniasis, Mucocutaneous
Article | Year |
---|---|
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Kidney Diseases; Leishmaniasis, Mucocutaneous; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Reference Values | 1997 |